Clinical Trial Update: Autologous Cell Therapy After Stroke [Phase 1]

View source ↗

Summary

The Phase 1 autologous cell therapy trial for stroke has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Autologous cell therapy

Snippet

Sponsor: University of California, Irvine | Conditions: Stroke | Phase 1 | Status: WITHDRAWN